Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma

Neoplasma

Volumn 61, Issue 4, 2014, Pages 453-460

  Li, X ^a   Yang, H ^c   Tian, Q ^b   Liu, Y ^b   Wang, M ^a   Ye, Z ^a   Weng, Y X ^b  

^a The First People's Hospital of Taizhou   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

MiR 17 92 cluster; Osteosarcoma; Overall survival; Prognosis; Recurrence free survival; Tumor progression

Indexed keywords

ALKALINE PHOSPHATASE; C REACTIVE PROTEIN; MICRORNA; MICRORNA 17 92; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY; TUMOR GROWTH; TUMOR RECURRENCE; UPREGULATION;

BONE NEOPLASMS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; OSTEOSARCOMA; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84904395061     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_056     Document Type: Article

References (34)

1. WEBER KL. What's new in musculoskeletal oncology. J Bone Joint Surg Am. 2005; 87: 1400-10. http://dx.doi.org/10.2106/JBJS.E.00257
2. WALKLEY CR, QUDSI R, SANKARAN VG, PERRY JA, GOSTISSA M, ET AL. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev. 2008; 22: 1662-76. http://dx.doi.org/10.1101/gad.1656808
3. TAN ML, CHOONG PF, DASS CR. Osteosarcoma: Conventional treatment vs. gene therapy. Cancer Biol Ther. 2009: 106-17. http://dx.doi.org/10.4161/cbt.8.2.7385
4. KLEIN MJ, SIEGAL GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006; 125: 555-81. http://dx.doi.org/10.1309/UC6KQHLD9LV2KENN
5. MIRABELLO L, TROISI RJ, SAVAGE SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009; 115: 1531-43. http://dx.doi.org/10.1002/cncr.24121
6. AMBROS V. MicroRNAs: tiny regulators with great potential. Cell. 2001; 107: 823-6. http://dx.doi.org/10.1016/S0092-8674(01)00616-X
7. KIM VN, HAN J, SIOMI MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009; 10: 126-39. http://dx.doi.org/10.1038/nrm2632
8. BARTEL DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97. http://dx.doi.org/10.1016/S0092-8674(04)00045-5
9. BETEL D, WILSON M, GABOW A, MARKS DS, SANDER C. The microRNA.org resource: targets and expression. Nucleic Acids Res. 2008; 36: D149-53. http://dx.doi.org/10.1093/nar/gkm995
10. Esquela-Kerscher A, SLACK FJ. Oncomirs microRNAs with a role in cancer. Nat Rev Cancer. 2006; 6: 259-69. http://dx.doi.org/10.1038/nrc1840
11. CALIN GA, CROCE CM. MicroRNA-cancer connection: the beginning of a new tale. Cancer Res. 2006; 66: 7390-4. http://dx.doi.org/10.1158/0008-5472.CAN-06-0800
12. CUMMINS JM, VELCULESCU VE. Implications of micro-RNA profiling for cancer diagnosis. Oncogene. 2006; 25: 6220-7. http://dx.doi.org/10.1038/sj.onc.1209914
13. AHMED FE. Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn. 2007; 7: 569-603. http://dx.doi.org/10.1586/14737159.7.5.569
14. CALIN GA, CROCE CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6: 857-66. http://dx.doi.org/10.1038/nrc1997
15. ASANGANI IA, RASHEED SA, NIKOLOVA DA, LEUPOLD JH, COLBURN NH, et al. MicroRNA-21 (miR-21) posttranscriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008; 27: 2128-36. http://dx.doi.org/10.1038/sj.onc.1210856
16. HE L, THOMSON JM, HEMANN MT, HERNANDOMONGE E, MU D, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005; 435: 828-33. http://dx.doi.org/10.1038/nature03552
17. BAUMHOER D, ZILLMER S, UNGER K, ROSEMANN M, ATKINSON MJ, et al. MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma. Cancer Genet. 2012; 205: 212-9. http://dx.doi.org/10.1016/j.cancergen.2012.03.001
18. TAGAWA H, SETO M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia. 2005; 19: 2013-6. http://dx.doi.org/10.1038/sj.leu.2403942
19. HAYASHITA Y, OSADA H, TATEMATSU Y, YAMADA H, YANAGISAWA K, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005; 65: 9628-32. http://dx.doi.org/10.1158/0008-5472.CAN-05-2352
20. NAMLOS HM, Meza-Zepeda LA, BARØY T, OSTENSEN IH, KRESSE SH, et al. Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One. 2012; 7: e48086. http://dx.doi.org/10.1371/journal.pone.0048086
21. LU Y, THOMSON JM, WONG HY, HAMMOND SM, HOGAN BL. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol. 2007; 310: 442-53. http://dx.doi.org/10.1016/j.ydbio.2007.08.007
22. HUANG G, NISHIMOTO K, ZHOU Z, HUGHES D, Klein-Erman ES. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res. 2012; 72: 908-16. http://dx.doi.org/10.1158/0008-5472.CAN-11-1460
23. ENNEKING WF, SPANIER SS, GOODMAN MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980; 153: 106-20.
24. DEWS M, HOMAYOUNI A, YU D, MURPHY D, Sevig-Nani C, et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet. 2006; 38: 1060-5. http://dx.doi.org/10.1038/ng1855
25. HENEGHAN HM, MILLER N, KERIN MJ. MiRNAs as biomarkers and therapeutic targets in cancer. Curr Opin Pharmacol. 2010; 10: 543-50. http://dx.doi.org/10.1016/j.coph.2010.05.010
26. JIN Y, PENG D, SHEN Y, XU M, LIANG Y, et al. MicroRNA-376c Inhibits Cell Proliferation and Invasion in Osteosarcoma by Targeting to Transforming Growth Factor-Alpha. DNA Cell Biol. 2013; 32: 302-9. http://dx.doi.org/10.1089/dna.2013.1977
27. MENDELL JT. MiRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008; 133: 217-22. http://dx.doi.org/10.1016/j.cell.2008.04.001
28. OLIVE V, BENNETT MJ, WALKER JC, MA C, JIANG I, et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 2009; 23: 2839-49. http://dx.doi.org/10.1101/gad.1861409
29. ODONNELL KA, WENTZEL EA, ZELLER KI, DANG CV, MENDELL JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005; 435: 839-43. http://dx.doi.org/10.1038/nature03677
30. MESTDAGH P, BOSTROM AK, IMPENS F, FREDLUND E, VAN PEER G, et al. The miR-17-92 microRNA cluster regulates multiple components of the TGF-beta pathway in neuroblastoma. Mol Cell. 2010; 40: 762-73. http://dx.doi.org/10.1016/j.molcel.2010.11.038
31. YU J, OHUCHIDA K, MIZUMOTO K, FUJITA H, NAKATA K, et al. MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion. Cancer Biol Ther. 2010; 10: 748-57. http://dx.doi.org/10.4161/cbt.10.8.13083
32. LIU M, WANG Z, YANG S, ZHANG W, HE S, et al. TNF-alpha is a novel target of miR-19a. Int J Oncol. 2011; 38: 1013-22.
33. YIN R, BAO W, XING Y, XI T, GOU S. MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells. Biochem Biophys Res Commun. 2012; 417: 771-6. http://dx.doi.org/10.1016/j.bbrc.2011.12.032
34. CONKRITE K, SUNDBY M, MUKAI S, THOMSON JM, MU D, et al. miR-17~92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev. 2011; 25: 1734-45. http://dx.doi.org/10.1101/gad.17027411